Eliot Forster - 31 Mar 2022 Form 4 Insider Report for F-star Therapeutics, Inc.

Role
President and CEO, Director
Signature
/s/ Darlene Deptula-Hicks, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
31 Mar 2022
Net transactions value
$0
Form type
4
Filing time
04 Apr 2022, 16:07:43 UTC
Previous filing
11 Jan 2022
Next filing
02 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FSTX Stock Option (right to buy) Award $0 +126,909 $0.000000 126,909 31 Mar 2022 Common Stock 126,909 $3.55 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted under the Issuer's 2019 Equity Incentive Plan.
F2 Twenty five percent (25%) of the total number of shares under the award shall vest on the first anniversary of the Vesting Commencement Date, March 31, 2022, and thereafter in 36 equal monthly installments such that the stock option shall be fully-vested on the fourth anniversary of the Vesting Commencement Date.